Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

New heart failure treatment shows promise | Vascular surgeon indicted for murder | Carotid stent impresses | SVD after TAVR

News You Need to Know Today
New heart failure treatment shows promise | Vascular surgeon indicted for murder | Carotid stent impresses | SVD after TAVR
Tuesday, January 20, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

New-look heart failure treatment shows early promise

Reducing the activity of a specific protein could provide significant relief for many heart failure patients.

READ MORE >
heart doctor cardiologist
Share on Twitter Share on Facebook Share on Linkedin

New-look heart failure treatment shows early promise

Share on Twitter Share on Facebook Share on Linkedin
heart doctor cardiologist
Reducing the activity of a specific protein could provide significant relief for many heart failure patients.
READ MORE >

Vascular surgeon indicted for murder of ex-wife and her husband

Michael McKee is accused of making the journey from Illinois to Ohio and then shooting the two victims in their home on Dec. 30. He was arrested after surveillance footage showed his car at the scene before and after the murders. 

READ MORE >
offender-trouble-handcuffs-police-arrest-2102488.jpg
Share on Twitter Share on Facebook Share on Linkedin

Vascular surgeon indicted for murder of ex-wife and her husband

Share on Twitter Share on Facebook Share on Linkedin
offender-trouble-handcuffs-police-arrest-2102488.jpg
Michael McKee is accused of making the journey from Illinois to Ohio and then shooting the two victims in their home on Dec. 30. He was arrested after surveillance footage showed his car at the scene before and after the murders. 
READ MORE >

Pivotal trial highlights safety, effectiveness of FDA-approved carotid stent

The CGuard Prime carotid stent system from InspireMD was approved by the FDA in 2025. These data confirm the device's ability to reduce a patient's stroke risk during treatment. 

READ MORE >
CGuard Prime carotid stent system was cleared by the U.S. Food and Drug Administration (FDA) in June 2025.
Share on Twitter Share on Facebook Share on Linkedin

Pivotal trial highlights safety, effectiveness of FDA-approved carotid stent

Share on Twitter Share on Facebook Share on Linkedin
CGuard Prime carotid stent system was cleared by the U.S. Food and Drug Administration (FDA) in June 2025.
The CGuard Prime carotid stent system from InspireMD was approved by the FDA in 2025. These data confirm the device's ability to reduce a patient's stroke risk during treatment. 
READ MORE >

Post-TAVR echocardiography helps predict a patient’s long-term risk of SVD

Postprocedural gradients can tell cardiologists a lot about a patient's long-term risk of structural valve deterioration.

READ MORE >
heart data research doctor cardiologist AI
Share on Twitter Share on Facebook Share on Linkedin

Post-TAVR echocardiography helps predict a patient’s long-term risk of SVD

Share on Twitter Share on Facebook Share on Linkedin
heart data research doctor cardiologist AI
Postprocedural gradients can tell cardiologists a lot about a patient's long-term risk of structural valve deterioration.
READ MORE >

Featured Articles

Abbott’s Navitor TAVR valve linked to positive real-world outcomes

The intra-annular, self-expanding Navitor valve gained FDA approval in 2023 for the treatment of high-risk heart patients with severe aortic stenosis. This analysis explores its early impact on patient care. 

READ MORE >
Navitor TAVR valve in the Abbott booth at TCT 2023. Photo by Dave Fornell
Share on Twitter Share on Facebook Share on Linkedin

Abbott’s Navitor TAVR valve linked to positive real-world outcomes

Share on Twitter Share on Facebook Share on Linkedin
Navitor TAVR valve in the Abbott booth at TCT 2023. Photo by Dave Fornell
The intra-annular, self-expanding Navitor valve gained FDA approval in 2023 for the treatment of high-risk heart patients with severe aortic stenosis. This analysis explores its early impact on patient care. 
READ MORE >

Heart teams playing a major role in coronary revascularization decisions

Sunil Rao, MD, discusses the heart team approach in the context of deciding what is best for the patient between bypass surgery and percutaneous coronary intervention.

READ MORE >
Sunil Rao, MD, director, interventional cardiology, cardiac catheterization laboratory, NYU Langone Heart, professor, Department of Medicine, the Leon H. Charney Division of Cardiology, NYU Grossman School of Medicine, discusses the heart team approach in the context to determining what is best for the patient in terms of bypass surgery or percutaneous coronary intervention.
Share on Twitter Share on Facebook Share on Linkedin

Heart teams playing a major role in coronary revascularization decisions

Share on Twitter Share on Facebook Share on Linkedin
Sunil Rao, MD, director, interventional cardiology, cardiac catheterization laboratory, NYU Langone Heart, professor, Department of Medicine, the Leon H. Charney Division of Cardiology, NYU Grossman School of Medicine, discusses the heart team approach in the context to determining what is best for the patient in terms of bypass surgery or percutaneous coronary intervention.
Sunil Rao, MD, discusses the heart team approach in the context of deciding what is best for the patient between bypass surgery and percutaneous coronary intervention.
READ MORE >

FDA confirms recalls for Abbott CGM sensors—new lawsuit alleges company concealed information

The FDA finalized four Class I recalls related to safety concerns first reported by Abbott in November. Meanwhile, a Florida man who uses these sensors to manage his diabetes has already filed a lawsuit over the issue.

READ MORE >
Abbott’s FreeStyle Libre 3 integrated continuous glucose monitoring (iCGM) system.
Share on Twitter Share on Facebook Share on Linkedin

FDA confirms recalls for Abbott CGM sensors—new lawsuit alleges company concealed information

Share on Twitter Share on Facebook Share on Linkedin
Abbott’s FreeStyle Libre 3 integrated continuous glucose monitoring (iCGM) system.
The FDA finalized four Class I recalls related to safety concerns first reported by Abbott in November. Meanwhile, a Florida man who uses these sensors to manage his diabetes has already filed a lawsuit over the issue.
READ MORE >

Heart failure experts share guidance on increasing prevention efforts

Cardiology has been shifting from reactionary treatment strategies to a greater emphasis on prevention. This is an especially important trend in heart failure, which is associated with high costs and rising hospitalization rates. 

READ MORE >
Cardiologist heart
Share on Twitter Share on Facebook Share on Linkedin

Heart failure experts share guidance on increasing prevention efforts

Share on Twitter Share on Facebook Share on Linkedin
Cardiologist heart
Cardiology has been shifting from reactionary treatment strategies to a greater emphasis on prevention. This is an especially important trend in heart failure, which is associated with high costs and rising hospitalization rates. 
READ MORE >

In Case You Missed It

FDA confirms new recall for Johnson & Johnson heart device over safety concerns

Three patient deaths have been linked to connectivity issues with these devices. The FDA has classified this as a Class I recall.

READ MORE >
FDA recall medical device recall product recall
Share on Twitter Share on Facebook Share on Linkedin

FDA confirms new recall for Johnson & Johnson heart device over safety concerns

Share on Twitter Share on Facebook Share on Linkedin
FDA recall medical device recall product recall
Three patient deaths have been linked to connectivity issues with these devices. The FDA has classified this as a Class I recall.
READ MORE >

New strategies for intravascular imaging and physiological assessments in the cath lab

"If you're not using an intravascular imaging modality, the PCI is not optimal," explained Haroon Faraz, MD, from Hackensack University Medical Center. Faraz is hopeful new and improved technologies will help these modalities become more popular among interventional cardiologists.

READ MORE >
 Advances in intravascular imaging and physiology assessment are reshaping how interventional cardiologists plan and optimize percutaneous coronary interventions (PCI), but workflow challenges continue to limit adoption, according to Haroon Faraz, MD, director of interventional cardiology and cardiovascular research at Hackensack University Medical Center.
Share on Twitter Share on Facebook Share on Linkedin

New strategies for intravascular imaging and physiological assessments in the cath lab

Share on Twitter Share on Facebook Share on Linkedin
 Advances in intravascular imaging and physiology assessment are reshaping how interventional cardiologists plan and optimize percutaneous coronary interventions (PCI), but workflow challenges continue to limit adoption, according to Haroon Faraz, MD, director of interventional cardiology and cardiovascular research at Hackensack University Medical Center.
"If you're not using an intravascular imaging modality, the PCI is not optimal," explained Haroon Faraz, MD, from Hackensack University Medical Center. Faraz is hopeful new and improved technologies will help these modalities become more popular among interventional cardiologists.
READ MORE >

Bleeding reversal agent pulled from market over FDA’s safety concerns

AstraZeneca has stopped selling Andexxa because randomized data suggested some patients may face an increased risk of certain adverse events. The company emphasized that it remains confident in the agent's abilities.

READ MORE >
warning safety alert recall healthcare issue
Share on Twitter Share on Facebook Share on Linkedin

Bleeding reversal agent pulled from market over FDA’s safety concerns

Share on Twitter Share on Facebook Share on Linkedin
warning safety alert recall healthcare issue
AstraZeneca has stopped selling Andexxa because randomized data suggested some patients may face an increased risk of certain adverse events. The company emphasized that it remains confident in the agent's abilities.
READ MORE >

In Other News

Most urgent head CTs for older adults provide little value

New findings suggest that the majority of older adults (65+) with lower risk head injuries do not have positive findings on CT imaging.

READ MORE >
hospital emergency room
Share on Twitter Share on Facebook Share on Linkedin

Most urgent head CTs for older adults provide little value

Share on Twitter Share on Facebook Share on Linkedin
hospital emergency room
New findings suggest that the majority of older adults (65+) with lower risk head injuries do not have positive findings on CT imaging.
READ MORE >

AI briefing: Hyped AI goes to the hospital | Is healthcare AI sustainable? | US & Israel power up AI partnership | more

Just because a healthcare AI product gets loudly promoted doesn’t mean its claims are bogus. The salient question is whether or not it performs as well in a clinical setting as it did in a research lab—or in a marketer’s mind. 

READ MORE >
United Imaging AI promotion RSNA 2023
Share on Twitter Share on Facebook Share on Linkedin

AI briefing: Hyped AI goes to the hospital | Is healthcare AI sustainable? | US & Israel power up AI partnership | more

Share on Twitter Share on Facebook Share on Linkedin
United Imaging AI promotion RSNA 2023
Just because a healthcare AI product gets loudly promoted doesn’t mean its claims are bogus. The salient question is whether or not it performs as well in a clinical setting as it did in a research lab—or in a marketer’s mind. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtronic announces $550M acquisition | Faster IVL catheter impresses | Who do Americans trust? | Burnout among surgeons
Cardiologist develops new heart device | FDA approves pacing lead for LBBAP | A warning about universal screening
News Alert: Medtronic announces $550M acquisition
Looking ahead to ACC.26 | Oversizing during TAVR boosts survival | Next-generation device delivers | AATS wants better research
Cardiology still a leader in AI | FDA details catheter recall | A key approval for Philips | Potential new gene therapies
Week in Review: FDA approves next-generation device | More recalls for Impella heart pumps | CMS targets cardiologists
News Alert: FDA warns public about reprocessed catheter recalls

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …15
    • Page 16
    • Page 17
    • Page 18
    • Current page 19
    • Page 20
    • Page 21
    • Page 22
    • Page 23 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup